The earnings call highlighted a strong quarterly performance with increased revenue in key segments and positive adjustments to guidance. Strategic acquisitions and product launches are expected to drive future growth. However, challenges such as international order delays, tariff impacts, and decreased operating margins were noted.

Company Guidance -

Q3 2025

During the Zimmer Biomet Second Quarter 2025 Earnings Conference Call, the company announced an update to its full-year guidance, reflecting confidence in a strong second half of 2025. The company raised its adjusted EPS guidance to a range of $8.10 to $8.30, up from the previous $7.90 to $8.10, and adjusted its full-year organic constant currency revenue growth expectation to 3.5% to 4.5%, excluding contributions from Paragon 28. This new range reflects a narrowed guidance from the prior range of 3% to 5%, with Paragon 28 expected to contribute 270 basis points to sales growth. Robust top-line growth was reported with a 2.8% increase in sales on an organic constant currency basis, driven by significant contributions from new product launches like the Z1 triple taper stem in the U.S. Hips segment, which saw a 5.2% increase. The U.S. Knees business showed a sequential improvement of 150 basis points, growing 1.7% year-over-year. The S.E.T. segment also reported solid growth at nearly 5%, marking the seventh consecutive quarter of mid-single-digit growth. Encouraging performance in product adoption and operational efficiencies, alongside a lower impact from tariffs and favorable foreign exchange rates, underpin the positive outlook.

Solid Quarterly Performance

Zimmer Biomet delivered a strong second quarter of 2025 with a 2.8% increase in sales on an organic constant currency basis, despite an 80 basis point selling day headwind.

U.S. Hips Revenue Growth

The U.S. Hips business grew by 5.2% over the prior year, accelerating from 3.7% growth in the first quarter of 2025.

U.S. Knees Revenue Increase

U.S. Knees increased sequentially by 150 basis points, growing 1.7% over the prior year period.

S.E.T. Segment Growth

The S.E.T. segment reported nearly 5% growth, with double-digit growth in Sports Medicine and CMFT and high single-digit growth in upper extremities.

Positive Adjustments to Guidance

Zimmer Biomet raised its 2025 adjusted earnings per share guidance to $8.10 to $8.30 from the previous range of $7.90 to $8.10.

Strategic Acquisition of Monogram Technologies

Zimmer Biomet announced the acquisition of Monogram Technologies, enhancing its robotic capabilities with the first robot to complete a fully autonomous surgery.

Zimmer Biomet Holdings (ZBH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ZBH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	1.88 / -	1.74	―	―	―
Aug 07, 2025	2025 (Q2)	1.98 / 2.07	2.01	2.99% (+0.06)	―
May 05, 2025	2025 (Q1)	1.77 / 1.81	1.94	-6.70% (-0.13)	―
Feb 06, 2025	2024 (Q4)	2.29 / 2.31	2.2	5.00% (+0.11)	―
Oct 30, 2024	2024 (Q3)	1.74 / 1.74	1.65	5.45% (+0.09)	―
Aug 07, 2024	2024 (Q2)	1.99 / 2.01	1.82	10.44% (+0.19)	―
May 02, 2024	2024 (Q1)	1.87 / 1.94	1.89	2.65% (+0.05)	―
Feb 08, 2024	2023 (Q4)	2.15 / 2.20	1.88	17.02% (+0.32)	―
Nov 07, 2023	2023 (Q3)	1.60 / 1.65	1.58	4.43% (+0.07)	―
Aug 01, 2023	2023 (Q2)	1.82 / 1.82	1.82	0.00% (0.00)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ZBH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$91.15	$98.43	+7.99%
May 05, 2025	$102.12	$90.24	-11.63%
Feb 06, 2025	$107.74	$102.20	-5.14%
Oct 30, 2024	$103.16	$109.05	+5.71%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zimmer Biomet Holdings (ZBH) report earnings?

Zimmer Biomet Holdings (ZBH) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).

What is Zimmer Biomet Holdings (ZBH) earnings time?

Zimmer Biomet Holdings (ZBH) earnings time is at Oct 29, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ZBH EPS forecast?

ZBH EPS forecast for the fiscal quarter 2025 (Q3) is 1.88.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing